Electromedical Technologies, Inc Quarterly Operating Income (Loss) in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Electromedical Technologies, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q2 2024.
  • Electromedical Technologies, Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$252K, a 26.2% increase year-over-year.
  • Electromedical Technologies, Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$869K, a 60.5% increase year-over-year.
  • Electromedical Technologies, Inc annual Operating Income (Loss) for 2023 was -$2.06M, a 28.8% decline from 2022.
  • Electromedical Technologies, Inc annual Operating Income (Loss) for 2022 was -$1.6M, a 57.8% increase from 2021.
  • Electromedical Technologies, Inc annual Operating Income (Loss) for 2021 was -$3.8M, a 20% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$869K -$252K +$89.6K +26.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$958K -$155K +$1.11M +87.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-06-14
Q4 2023 -$2.06M -$223K +$34.4K +13.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-05-01
Q3 2023 -$2.1M -$239K +$98.3K +29.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$2.2M -$341K -$58.1K -20.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$2.14M -$1.26M -$536K -73.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-06-14
Q4 2022 -$1.6M -$257K +$1.23M +82.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-05-01
Q3 2022 -$2.84M -$337K -$117K -53% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$2.72M -$283K +$241K +46% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$2.96M -$726K +$839K +53.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$3.8M -$1.49M -$1.67M -910% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$2.13M -$221K +$1.87M +89.5% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-11-23
Q2 2021 -$4M -$525K +$293K +35.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$4.29M -$1.56M -$1.13M -257% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$3.17M $184K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$2.09M -$1.92M -1074% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$818K -$622K -317% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-09-03
Q1 2020 -$438K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 -$178K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$196K Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.